It plays a role in the detoxification of environmental carcinogen metabolites, suggesting that its downregulation may contribute to HCC carcinogenesis secondary to ROS-facilitated oxidative damage.51 The expression of GSTM1 was much higher in the KM and silymarin treatment groups versus control and DEN groups. Here, GSTM1 is linked to hepatocellular carcinoma.